Dow drops 350 points after Moderna CEO warns it will take MONTHS to develop Omicron vaccine
U.S. stocks opened sharply lower on Tuesday after a warning from vaccine maker Moderna's CEO that COVID-19 shots could be less effective against Omicron variant.